Abbott

NYSE ABT · Abbott Park, IL

Works in GI & liver · Infectious disease · Metabolic & endocrine · Renal & urogenital · Respiratory · Women's health

Abbott is a clinical trial sponsor based in Abbott Park, IL, listed as NYSE ABT. It has 1 active clinical trial with 250 planned participants, across 6 therapeutic areas. Since 2021 it has completed 10 trials and stopped 0 early. Its FDA record on file shows 1 recall.

Trial track record · since 2021

1Active trials250 planned participants
10Completed4 with results posted
0Stopped early0% of finished trials

FDA record

0InspectionsNone posted since 2025
0Warning lettersNone on file
1RecallLatest 2026-10-28: Class II

Recent FDA actions

Financials · NYSE ABT

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 1 active trial

StageTrialStatus

On the market

1 approved drug application with a product on the market.

Questions about Abbott

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-04-03.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with Abbott.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.